Clinical trial protocol1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer
作者
Stephanie L. Wethington,Payal D. Shah,Lainie P. Martin,János L. Tanyi,Nawar Latif,Mark A. Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Dean,Susan M. Domchek,Ronny Drapkin,Ie‐Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah K. Armstrong,Stéphanie Gaillard,Robert Giuntoli,Fiona Simpkins
PDF的下载单位、IP信息已删除
(2025-6-4)
张欢馨
woshi123
cdercder
Kao
22336
Criminology34
aubusson
v0id
yjh123
MchemG
丰富语蕊
Oracle
aajhajkahna
十三
科研狗
CRUSADER
学术文献互助
ming2026
OK
vampv
皖公网安备34019202002308
